Abstract

Whole organ decellularization techniques have facilitated the fabrication of extracellular matrices (ECMs) for engineering new organs. Unfortunately, there is no objective gold standard evaluation of the scaffold without applying a destructive method such as histological analysis or DNA removal quantification of the dry tissue. Our proposal is a software application using deep convolutional neural networks (DCNN) to distinguish between different stages of decellularization, determining the exact moment of completion. Hearts from male Sprague Dawley rats (n = 10) were decellularized using 1% sodium dodecyl sulfate (SDS) in a modified Langendorff device in the presence of an alternating rectangular electric field. Spectrophotometric measurements of deoxyribonucleic acid (DNA) and total proteins concentration from the decellularization solution were taken every 30 min. A monitoring system supervised the sessions, collecting a large number of photos saved in corresponding folders. This system aimed to prove a strong correlation between the data gathered by spectrophotometry and the state of the heart that could be visualized with an OpenCV-based spectrometer. A decellularization completion metric was built using a DCNN based classifier model trained using an image set comprising thousands of photos. Optimizing the decellularization process using a machine learning approach launches exponential progress in tissue bioengineering research.

Highlights

  • Cardiovascular diseases continue to be a challenge in medicine, being the leading cause of death worldwide [1]

  • We described a method for characterization of the extracellular matrices (ECMs) by determining the concentration of deoxyribonucleic acid (DNA) and proteins in the perfusion solution

  • Whole-Heart examined for Decellularization structural integrity and preservation of native ECM

Read more

Summary

Introduction

Cardiovascular diseases continue to be a challenge in medicine, being the leading cause of death worldwide [1]. Heart transplantation remains the gold standard treatment, organ donation is limited by the poor number of available replacements [2]. Complications such as immune rejection, drug-induced side effects because of chronic immunosuppression negatively interfere with the lifetime of the surgical substitution [3]. Immune rejection after transplantation is caused by antigens which initiate an immune response by the host, causing graft failure and recipient death [4]. Researchers in cardiovascular tissue engineering started to provide novel solutions for end-stage heart diseases to address these limitations. Some focus on increasing the availability of organs, while others on reducing the immune response to donor hearts

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call